Last reviewed · How we verify
acetaminophen sustained-release
At a glance
| Generic name | acetaminophen sustained-release |
|---|---|
| Sponsor | Dr. Marco L.A. Sivilotti |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Phase 3 Study of F14 for Management of Pain Following Total Knee Replacement (PHASE3)
- Bowen Technique Versus Dynamic Soft Tissue Mobilization on Pain, Range of Motion and Functional Disability in Patients With Adhesive Capsulitis (NA)
- Acetaminophen-induced Hepatotoxicity in Chronic Alcohol Abusers (NA)
- Assessment of the Pharmacokinetics of a Sustained Release Formulation of a Tramadol/Acetaminophen Combination (PHASE1)
- Exploratory Study to Investigate Cognition Function and Mobility in Individuals With Pain (PHASE4)
- Assess the Blood-Oxygen-Level-Dependent (BOLD) Signal Changes in the Brain by Paracetamol as Measured by Functional Magnetic Resonance Imaging (fMRI) in Subjects With Osteoarthritis (OA) (PHASE4)
- A Comparison of the Addiction Liability of Hydrocodone and Sustained Release Morphine (PHASE4)
- A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- acetaminophen sustained-release CI brief — competitive landscape report
- acetaminophen sustained-release updates RSS · CI watch RSS
- Dr. Marco L.A. Sivilotti portfolio CI